-
Animal models of chronic thromboembolic pulmonary hypertension
-
Advances and perspectives in animal models of human hepatitis A virus
-
Recent advances in the construction of humanized animal models and applications in translational medicine
-
Animal models of idiopathic membranous nephropathy: Recent advances and future perspectives
-
Research progress in animal models of dry eye disease: Types, mechanisms, and application prospects
-
Animal models in molecular biology research: Challenges, ethical imperatives, and the path to human‐relevant translation
-
Lung maneuvers of large amplitudes for probing physiological alterations in mouse models of asthma
-
Livogrit Ameliorates Thioacetamide-Induced Liver Fibrosis and Dyslipidemia in Rat Model by Regulating Oxidative Stress and Hepatic Collagen Levels, in a Non-Mutagenic Manner
-
Development of pharmaceutical compositions based on animal and plant-derived squalene
-
Edible Fungus Compound Cordycepin Protects Against Acetaminophen‐Induced Liver Injury
-
Validation of a Multiparametric, Automated, Macroarray‐Based Assay for the Detection of Autoantibodies in Autoimmune Liver Disease
-
Molecular characterization of the A52 murine hepatocellular carcinoma cell line
-
Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication
-
Toxicological Evaluation of the Liver and Kidneys of Rats Exposed to Myrothamnus Flabellifolius Crude Aqueous Extract
-
The liver‐brain axis: A multidimensional regulatory network implicated in Alzheimer's disease pathogenesis and clinical implications
-
Animal research in the UK: Regulation, implementation, welfare and development of new approach methodologies
-
Development of immunocompetent models for primary and metastatic ER+ breast cancer
-
A microscopically assisted limited colectomy mouse model of early colon cancer
-
Cell therapy comparison of dental pulp stem cells, hepatocytes, and their exosomes for liver fibrosis treatment in rats
-
Sex as a biological variable in nonclinical studies: Bridging scientific rigor, animal welfare, and regulatory expectations
-
IGFBP3 As a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma: A Multi‐Cohort Analysis
-
IRF‐1 modulates hepatic ferroptosis and aggravates liver ischemia/reperfusion injury via DYRK1α
-
A preclinical mouse model mimicking the ovarian cancer‐induced estrogen deficiency‐depression axis
-
Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study
